INSUBCONTINENT EXCLUSIVE:
Pharmaceutical company Eli Lilly has said a mid-stage trial of its next-generation obesity drug candidate "triple G" showed that it led to
weight loss of up to 24.2pc after 48 weeks, surpassing results seen with other weight loss drugs.
